basic fibroblast growth factor bfgf (Miltenyi Biotec)
Miltenyi Biotec is a verified supplier 
Miltenyi Biotec manufactures this product 
95
Structured Review
Miltenyi Biotec
basic fibroblast growth factor bfgf
Basic Fibroblast Growth Factor Bfgf, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 147 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bfgf/Human+FGF-2%2C+premium+grade/pm42336896-211-24-29
Average 95 stars, based on 147 article reviews
Basic Fibroblast Growth Factor Bfgf, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 147 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bfgf/Human+FGF-2%2C+premium+grade/pm42336896-211-24-29
Average 95 stars, based on 147 article reviews
basic fibroblast growth factor bfgf - by Bioz Stars,
2026-09
95/100 stars
Images
Related Articles
Cell Culture:Article Title: Integrative multi-omics combined with functional pharmacological profiling in patient-derived organoids identifies personalized therapeutic vulnerabilities of adult high-grade gliomas Article Snippet: .. GSCs were cultured as 3D spheres in serum-free DMEM-F12 medium (Lonza) containing 1 x BIT100 (Provitro), 2 mM L-Glutamine, 30 U/ml Pen-Strep, 1 U/ml Heparin (Sigma), 20 ng/ml bFGF (Miltenyi, 130-093-841) and 20 ng/ml EGF (Provitro, 1325950500) (NCH601, NCH421k, NCH644) or serum-free Neurobasal medium (Thermo Fisher, Cat# 21103049) supplemented with 1X B-27TM Supplement (Thermo Fisher, Cat# 17504044), 2 mM UltraGlutamine (LONZA, Cat#BE17-605E/U1), 0,1 U/mL heparin (Sigma-Aldrich, Cat# H3149), 20 ng/mL Article Title: Modeling common Alzheimer's disease with high and low polygenic risk in human iPSC: A large-scale research resource. Article Snippet: Vector transduced cells were transferred onto mitotically inactivated CF1 Mouse Embryonic Feeder cells (Millipore, PMEF-CFL-C) on 0.1% gelatin (Sigma, G1393)-coated plates. .. From day 3, cells were cultured in Knock-Out serum replacement medium (Knock-out DMEM [Gibco, 10829-018], 20% KO serum replacement [Gibco, 10828-028], 2 mM Glutamax [Gibco, 35030-1], 1% non-essential amino acids [Gibco, 11140-035], 100 units/ mL penicillin and 100 μg/mL streptomycin [Gibco, 15140- 122], 55 μM 2-mercaptoethanol [Gibco, 31350-010], and 5 ng/mL Article Title: FGFR1 drives metabolic adaptation associated with temozolomide resistance in glioblastoma. Article Snippet: Therapy resistance is a major limitation in therapeutic efficacy for glioblastoma (GBM) patients, positioning GBM among the deadliest tumor types.. In this work, we have dissected resistance mechanisms in GBM, which resulted in the identification of FGFR1 pathway as a major controller of the signaling and metabolic rewiring associated to temozolomide (TMZ) resistance.. Hence, in FGFR1-positive, p53 WT GBM cells, FGFR1 controls a p53-mediated cell cycle arrest to allow DNA repair in response to TMZ. Article Title: Modeling common Alzheimer’s disease with high and low polygenic risk in human iPSC: A large-scale research resource Article Snippet: Vector transduced cells were transferred onto mitotically inactivated CF1 Mouse Embryonic Feeder cells (Millipore, PMEF-CFL-C) on 0.1% gelatin (Sigma, G1393)-coated plates. .. From day 3, cells were cultured in Knock-Out serum replacement medium (Knock-out DMEM [Gibco, 10829-018], 20% KO serum replacement [Gibco, 10828-028], 2 mM Glutamax [Gibco, 35030-1], 1% non-essential amino acids [Gibco, 11140-035], 100 units/mL penicillin and 100 μg/mL streptomycin [Gibco, 15140-122], 55 μM 2-mercaptoethanol [Gibco, 31350-010], and 5 ng/mL Knock-Out:Article Title: Modeling common Alzheimer's disease with high and low polygenic risk in human iPSC: A large-scale research resource. Article Snippet: Vector transduced cells were transferred onto mitotically inactivated CF1 Mouse Embryonic Feeder cells (Millipore, PMEF-CFL-C) on 0.1% gelatin (Sigma, G1393)-coated plates. .. From day 3, cells were cultured in Knock-Out serum replacement medium (Knock-out DMEM [Gibco, 10829-018], 20% KO serum replacement [Gibco, 10828-028], 2 mM Glutamax [Gibco, 35030-1], 1% non-essential amino acids [Gibco, 11140-035], 100 units/ mL penicillin and 100 μg/mL streptomycin [Gibco, 15140- 122], 55 μM 2-mercaptoethanol [Gibco, 31350-010], and 5 ng/mL Article Title: Modeling common Alzheimer’s disease with high and low polygenic risk in human iPSC: A large-scale research resource Article Snippet: Vector transduced cells were transferred onto mitotically inactivated CF1 Mouse Embryonic Feeder cells (Millipore, PMEF-CFL-C) on 0.1% gelatin (Sigma, G1393)-coated plates. .. From day 3, cells were cultured in Knock-Out serum replacement medium (Knock-out DMEM [Gibco, 10829-018], 20% KO serum replacement [Gibco, 10828-028], 2 mM Glutamax [Gibco, 35030-1], 1% non-essential amino acids [Gibco, 11140-035], 100 units/mL penicillin and 100 μg/mL streptomycin [Gibco, 15140-122], 55 μM 2-mercaptoethanol [Gibco, 31350-010], and 5 ng/mL Clinical Proteomics:Article Title: Blood-perfused Vessels-on-Chips stimulated with patient plasma recapitulate endothelial activation and microthrombosis in COVID-19 Article Snippet: .. HiPSC-ECs were expanded human endothelial serum-free medium (EC-SFM, Gibco) supplemented with 1% platelet poor plasma (human, Sigma), 30 ng ml −1 VEGF (Recombinant Human VEGF 165, Miltenyi Biotec) and 20 ng ml −1 Recombinant:Article Title: Blood-perfused Vessels-on-Chips stimulated with patient plasma recapitulate endothelial activation and microthrombosis in COVID-19 Article Snippet: .. HiPSC-ECs were expanded human endothelial serum-free medium (EC-SFM, Gibco) supplemented with 1% platelet poor plasma (human, Sigma), 30 ng ml −1 VEGF (Recombinant Human VEGF 165, Miltenyi Biotec) and 20 ng ml −1 other:Article Title: Ubiquitous MEIS transcription factors actuate lineage-specific transcription to establish cell fate Article Snippet: |